Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Jean Costentin

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Living Beings

Chemicals & Drugs

Activities & Behaviors

Concepts & Ideas

Drug Dose-Response Relationship

Anatomy

Procedures

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Foucout Lénaïg; Gourand Fabienne; Dhilly Martine; Bohn Pierre; Dupas Georges; Costentin Jean; Abbas Ahmed; Marsais Francis; Barré Louisa; Levacher Vincent
Synthesis, radiosynthesis and biological evaluation of 1,4-dihydroquinoline derivatives as new carriers for specific brain delivery.
El Yacoubi Malika; Ledent Catherine; Parmentier Marc; Costentin Jean; Vaugeois Jean-Marie
Adenosine A2A receptor deficient mice are partially resistant to limbic seizures.
Bohn Pierre; Le Fur Nicolas; Hagues Guillaume; Costentin Jean; Torquet Nicolas; Papamicaël Cyril; Marsais Francis; Levacher Vincent
Rational design of central selective acetylcholinesterase inhibitors by means of a "bio-oxidisable prodrug" strategy.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Jean Costentin (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Foucout Lénaïg; Gourand Fabienne; Dhilly Martine; Bohn Pierre; Dupas Georges; Costentin Jean; Abbas Ahmed; Marsais Francis; Barré Louisa; Levacher Vincent
Synthesis, radiosynthesis and biological evaluation of 1,4-dihydroquinoline derivatives as new carriers for specific brain delivery.
Organic & biomolecular chemistry 2009;7(18):3666-73.
2009: El Yacoubi Malika; Ledent Catherine; Parmentier Marc; Costentin Jean; Vaugeois Jean-Marie
Adenosine A2A receptor deficient mice are partially resistant to limbic seizures.
Naunyn-Schmiedeberg's archives of pharmacology 2009;380(3):223-32.
2009: Bohn Pierre; Le Fur Nicolas; Hagues Guillaume; Costentin Jean; Torquet Nicolas; Papamicaël Cyril; Marsais Francis; Levacher Vincent
Rational design of central selective acetylcholinesterase inhibitors by means of a "bio-oxidisable prodrug" strategy.
Organic & biomolecular chemistry 2009;7(12):2612-8.
2009: Pelloux Yann; Costentin Jean; Duterte-Boucher Dominique
Anxiety increases the place conditioning induced by cocaine in rats.
Behavioural brain research 2009;197(2):311-6.
2008: Viana Af; Rates Smk; Naudin B; Janin F; Costentin J; do Rego J-C
Effects of acute or 3-day treatments of Hypericum caprifoliatum Cham. & Schltdt. (Guttiferae) extract or of two established antidepressants on basal and stress-induced increase in serum and brain corticosterone levels.
Journal of psychopharmacology (Oxford, England) 2008;22(6):681-90.
2008: El Yacoubi Malika; Ledent Catherine; Parmentier Marc; Costentin Jean; Vaugeois Jean-Marie
Evidence for the involvement of the adenosine A(2A) receptor in the lowered susceptibility to pentylenetetrazol-induced seizures produced in mice by long-term treatment with caffeine.
Neuropharmacology 2008;55(1):35-40.
2008: Hagues Guillaume; Costentin Jean; Duterte-Boucher Dominique
Locomotor effects of morphine or alcohol in mice after a repeated treatment with the cannabinoid agonist HU 210.
European journal of pharmacology 2008;586(1-3):197-204.
2008: do Rego Jean-Claude; Leprince Jérôme; Scalbert Elizabeth; Vaudry Hubert; Costentin Jean
Behavioral actions of urotensin-II.
Peptides 2008;29(5):838-44.
2008: Fichna Jakub; do-Rego Jean-Claude; Chung Nga N; Costentin Jean; Schiller Peter W; Janecka Anna
[Dmt1, d-1-Nal3]morphiceptin, a novel opioid peptide analog with high analgesic activity.
Peptides 2008;29(4):633-8.
2008: Bredeloux Pierre; Cavelier Florine; Dubuc Isabelle; Vivet Bertrand; Costentin Jean; Martinez Jean
Synthesis and biological effects of c(Lys-Lys-Pro-Tyr-Ile-Leu-Lys-Lys-Pro-Tyr-Ile-Leu) (JMV2012), a new analogue of neurotensin that crosses the blood-brain barrier.
Journal of medicinal chemistry 2008;51(6):1610-6.
2008: Fichna Jakub; do-Rego Jean-Claude; Janecki Tomasz; Staniszewska Renata; Poels Jeroen; Broeck Jozef Vanden; Costentin Jean; Schiller Peter W; Janecka Anna
Novel highly potent mu-opioid receptor antagonist based on endomorphin-2 structure.
Bioorganic & medicinal chemistry letters 2008;18(4):1350-3.
2007: Billet F; Costentin J; Dourmap N
Influence of glial cells in the dopamine releasing effect resulting from the stimulation of striatal delta-opioid receptors.
Neuroscience 2007;150(1):131-43.
2007: do Rego Jean-Claude; Benkiki Naïma; Chosson Elizabeth; Kabouche Zahia; Seguin Elisabeth; Costentin Jean
Antidepressant-like effect of hyperfoliatin, a polyisoprenylated phloroglucinol derivative from Hypericum perfoliatum (Clusiaceae) is associated with an inhibition of neuronal monoamines uptake.
European journal of pharmacology 2007;569(3):197-203.
2007: do Rego Jean-Claude; Orta Marie-Hélène; Leprince Jérôme; Tonon Marie-Christine; Vaudry Hubert; Costentin Jean
Pharmacological characterization of the receptor mediating the anorexigenic action of the octadecaneuropeptide: evidence for an endozepinergic tone regulating food intake.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2007;32(7):1641-8.
2007: Fichna Jakub; Janecka Anna; Piestrzeniewicz Mariola; Costentin Jean; do Rego Jean-Claude
Antidepressant-like effect of endomorphin-1 and endomorphin-2 in mice.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2007;32(4):813-21.
2007: Fichna Jakub; Janecka Anna; Costentin Jean; Do Rego Jean-Claude
The endomorphin system and its evolving neurophysiological role.
Pharmacological reviews 2007;59(1):88-123.
2007: Bredeloux P; Dubuc I; Costentin J
Comparisons between bupropion and dexamphetamine in a range of in vivo tests exploring dopaminergic transmission.
British journal of pharmacology 2007;150(6):711-9.
2007: Hagues Guillaume; Costentin Jean; Duterte-Boucher Dominique
Modulation of morphine and alcohol motor stimulant effects by cannabinoid receptors ligands.
Behavioural brain research 2007;178(2):274-82.
2007: Fichna Jakub; do-Rego Jean-Claude; Chung Nga N; Lemieux Carole; Schiller Peter W; Poels Jeroen; Broeck Jozef Vanden; Costentin Jean; Janecka Anna
Synthesis and characterization of potent and selective mu-opioid receptor antagonists, [Dmt(1), D-2-Nal(4)]endomorphin-1 (Antanal-1) and [Dmt(1), D-2-Nal(4)]endomorphin-2 (Antanal-2).
Journal of medicinal chemistry 2007;50(3):512-20.
2006: Viana Alice F; do Rego Jean-Claude; Munari Leonardo; Dourmap Nathalie; Heckler Ana Paula; Costa Teresa Dalla; von Poser Gilsane L; Costentin Jean; Rates Stela M K
Hypericum caprifoliatum (Guttiferae) Cham. & Schltdl.: a species native to South Brazil with antidepressant-like activity.
Fundamental & clinical pharmacology 2006;20(6):507-14.
2006: Bredeloux Pierre; Costentin Jean; Dubuc Isabelle
Interactions between NTS2 neurotensin and opioid receptors on two nociceptive responses assessed on the hot plate test in mice.
Behavioural brain research 2006;175(2):399-407.
2006: Costentin Jean
[Good use of the word "drogue" in French language]
Thérapie 2006;61(6):553-4.
2006: do Rego Jean-Claude; Leprince Jérôme; Chartrel Nicolas; Vaudry Hubert; Costentin Jean
Behavioral effects of 26RFamide and related peptides.
Peptides 2006;27(11):2715-21.
2006: Fichna Jakub; Janecka Anna; Bailly Laetitia; Marsais Francis; Costentin Jean; do Rego Jean-Claude
In vitro characterization of novel peptide inhibitors of endomorphin-degrading enzymes in the rat brain.
Chemical biology & drug design 2006;68(3):173-5.
2006: Le Maître Erwan; Daubeuf François; Duterte-Boucher Dominique; Costentin Jean; Leroux-Nicollet Isabelle
Coupling of ORL1 (NOP) receptor to G proteins is decreased in the nucleus accumbens of anxious relative to non-anxious mice.
Brain research 2006;1110(1):144-9.
2006: El Yacoubi Malika; Vaugeois Jean-Marie; Marguet Didier; Sauze Nicole; Guieu Régis; Costentin Jean; Fenouillet Emmanuel
Behavioral characterization of CD26 deficient mice in animal tests of anxiety and antidepressant-like activity.
Behavioural brain research 2006;171(2):279-85.
2006: Fichna Jakub; do-Rego Jean-Claude; Kosson Piotr; Schiller Peter W; Costentin Jean; Janecka Anna
[(35)S]GTPgammaS binding stimulated by endomorphin-2 and morphiceptin analogs.
Biochemical and biophysical research communications 2006;345(1):162-8.
2006: Pelloux Yann; Costentin Jean; Duterte-Boucher Dominique
Novelty preference predicts place preference conditioning to morphine and its oral consumption in rats.
Pharmacology, biochemistry, and behavior 2006;84(1):43-50.
2006: Chartrel Nicolas; Bruzzone Federica; Leprince Jérôme; Tollemer Hélène; Anouar Youssef; Do-Régo Jean-Claude; Ségalas-Milazzo Isabelle; Guilhaudis Laure; Cosette Pascal; Jouenne Thierry; Simonnet Guy; Vallarino Mauro; Beauvillain Jean-Claude; Costentin Jean; Vaudry Hubert
Structure and functions of the novel hypothalamic RFamide neuropeptides R-RFa and 26RFa in vertebrates.
Peptides 2006;27(5):1110-20.
2006: do-Rego Jean-Claude; Viana Alice F; Le Maître Erwan; Deniel Audrey; Rates Stela M K; Leroux-Nicollet Isabelle; Costentin Jean
Comparisons between anxiety tests for selection of anxious and non anxious mice.
Behavioural brain research 2006;169(2):282-8.
2005: Janecka Anna; Fichna Jakub; Kruszynski Rafal; Sasaki Yusuke; Ambo Akihiro; Costentin Jean; do-Rego Jean-Claude
Synthesis and antinociceptive activity of cyclic endomorphin-2 and morphiceptin analogs.
Biochemical pharmacology 2005;71(1-2):188-95.
2005: Kruszynski Rafal; Fichna Jakub; do-Rego Jean-Claude; Janecki Tomasz; Kosson Piotr; Pakulska Wanda; Costentin Jean; Janecka Anna
Synthesis and biological activity of N-methylated analogs of endomorphin-2.
Bioorganic & medicinal chemistry 2005;13(24):6713-7.
2005: Viana Alice; do Rego Jean-Claude; von Poser Gilsane; Ferraz Alexandre; Heckler Ana Paula; Costentin Jean; Kuze Rates Stela Maris
The antidepressant-like effect of Hypericum caprifoliatum Cham & Schlecht (Guttiferae) on forced swimming test results from an inhibition of neuronal monoamine uptake.
Neuropharmacology 2005;49(7):1042-52.
2005: Do-Rego Jean-Claude; Chatenet David; Orta Marie-Hélène; Naudin Bertrand; Le Cudennec Camille; Leprince Jérôme; Scalbert Elizabeth; Vaudry Hubert; Costentin Jean
Behavioral effects of urotensin-II centrally administered in mice.
Psychopharmacology 2005;183(1):103-17.
2005: El Yacoubi Malika; Ledent Catherine; Parmentier Marc; Costentin Jean; Vaugeois Jean-Marie
Reduced appetite for caffeine in adenosine A(2A) receptor knockout mice.
European journal of pharmacology 2005;519(3):290-1.
2005: Kruszynski R; Fichna J; do-Rego J-C; Chung N N; Schiller P W; Kosson P; Costentin J; Janecka A
Novel endomorphin-2 analogs with mu-opioid receptor antagonist activity.
The journal of peptide research : official journal of the American Peptide Society 2005;66(3):125-31.
2005: Suaudeau Charles; do-Rego Jean-Claude; Costentin Jean
Modifications in avoidance reactions of mice, on a second exposure to the hot plate, resist to various amnesia-inducing treatments.
Brain research. Cognitive brain research 2005;25(1):339-47.
2005: Vautrin Sandrine; Pelloux Yann; Costentin Jean
Preference for caffeine appears earlier in non-anxious than in anxious mice.
Neuroscience letters 2005;386(2):94-8.
2005: Le Maître Erwan; Vilpoux Catherine; Costentin Jean; Leroux-Nicollet Isabelle
Opioid receptor-like 1 (NOP) receptors in the rat dorsal raphe nucleus: evidence for localization on serotoninergic neurons and functional adaptation after 5,7-dihydroxytryptamine lesion.
Journal of neuroscience research 2005;81(4):488-96.
2005: Chartrel Nicolas; Bruzzone Federica; Dujardin Cynthia; Leprince Jerome; Tollemer Helene; Anouar Youssef; Vallarino Mauro; Costentin Jean; Vaudry Hubert
Identification of 26RFa from frog brain: a novel hypothalamic neuropeptide with orexigenic activity in mammals.
Annals of the New York Academy of Sciences 2005;1040():80-3.
2005: Fichna J; do-Rego J-C; Mirowski M; Costentin J; Janecka A
Binding of endomorphin-2 to mu-opioid receptors in experimental mouse mammary adenocarcinoma.
The journal of peptide research : official journal of the American Peptide Society 2005;65(4):459-64.
2005: Pelloux Yann; Hagues Guillaume; Costentin Jean; Duterte-Boucher Dominique
Helplessness in the tail suspension test is associated with an increase in ethanol intake and its rewarding effect in female mice.
Alcoholism, clinical and experimental research 2005;29(3):378-88.
2005: Fichna Jakub; do-Rego Jean-Claude; Kosson Piotr; Costentin Jean; Janecka Anna
Characterization of antinociceptive activity of novel endomorphin-2 and morphiceptin analogs modified in the third position.
Biochemical pharmacology 2005;69(1):179-85.
2004: Billet Fabrice; Dourmap Nathalie; Costentin Jean
Involvement of corticostriatal glutamatergic terminals in striatal dopamine release elicited by stimulation of delta-opioid receptors.
The European journal of neuroscience 2004;20(10):2629-38.
2004: Chartrel Nicolas; Costentin Jean; Vaudry Hubert
[The frog who wished to be as big as an ox: characterization in amphibians of a novel neuropeptide that stimulates appetite in mammals]
Médecine sciences : M/S 2004;20(10):839-42.
2004: Vaugeois J-M; El Yacoubi M; Costentin J
[Comments on an animal model of depression]
Annales pharmaceutiques françaises 2004;62(5):332-42.
2004: Bonnet J-J; Legros H; Janin Fr; Dourmap N; Costentin J
[Assessment of the in vitro and in vivo toxicity of 3,4-dihydroxyphenylacetaldehyde (DOPAL)]
Annales pharmaceutiques françaises 2004;62(5):323-31.
2004: Fichna Jakub; do-Rego Jean-Claude; Costentin Jean; Chung Nga N; Schiller Peter W; Kosson Piotr; Janecka Anna
Opioid receptor binding and in vivo antinociceptive activity of position 3-substituted morphiceptin analogs.
Biochemical and biophysical research communications 2004;320(2):531-6.
2004: Costentin J
[Physiological and neurobiological elements of food intake]
Annales pharmaceutiques françaises 2004;62(2):92-102.
2004: Legros Hélène; Dingeval Marie-George; Janin François; Costentin Jean; Bonnet Jean-Jacques
Toxicity of a treatment associating dopamine and disulfiram for catecholaminergic neuroblastoma SH-SY5Y cells: relationships with 3,4-dihydroxyphenylacetaldehyde formation.
Neurotoxicology 2004;25(3):365-75.
2004: Legros Hélène; Janin François; Dourmap Nathalie; Bonnet Jean-Jacques; Costentin Jean
Semi-chronic increase in striatal level of 3,4-dihydroxyphenylacetaldehyde does not result in alteration of nigrostriatal dopaminergic neurones.
Journal of neuroscience research 2004;75(3):429-35.
2004: Costentin Jean
[The importance of in vivo pharmacology in fundamental research on psychotropic drugs and their biological targets]
Thérapie 2004;59(1):51-6.
2004: Pelloux Y; Costentin J; Duterte-Boucher D
Differential effects of novelty exposure on place preference conditioning to amphetamine and its oral consumption.
Psychopharmacology 2004;171(3):277-85.
2004: Loutelier-Bourhis C; Legros H; Bonnet J-J; Costentin J; Lange C M
Gas chromatography/mass spectrometric identification of dopaminergic metabolites in striata of rats treated with L-DOPA.
Rapid communications in mass spectrometry : RCM 2004;18(5):571-6.
2003: El Yacoubi Malika; Costentin Jean; Vaugeois Jean-Marie
Adenosine A2A receptors and depression.
Neurology 2003;61(11 Suppl 6):S82-7.
2003: Chartrel Nicolas; Dujardin Cynthia; Anouar Youssef; Leprince Jérôme; Decker Annick; Clerens Stefan; Do-Régo Jean-Claude; Vandesande Frans; Llorens-Cortes Catherine; Costentin Jean; Beauvillain Jean-Claude; Vaudry Hubert
Identification of 26RFa, a hypothalamic neuropeptide of the RFamide peptide family with orexigenic activity.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(25):15247-52.
2003: Jégou S; El Yacoubi M; Mounien L; Ledent C; Parmentier M; Costentin J; Vaugeois J-M; Vaudry H
Adenosine A2A receptor gene disruption provokes marked changes in melanocortin content and pro-opiomelanocortin gene expression.
Journal of neuroendocrinology 2003;15(12):1171-7.
2003: El Yacoubi M; Ledent C; Parmentier M; Costentin J; Vaugeois J-M
Caffeine reduces hypnotic effects of alcohol through adenosine A2A receptor blockade.
Neuropharmacology 2003;45(7):977-85.
2003: Cleren Carine; Naudin Bertrand; Costentin Jean
Apparent opposite effects of tetrabenazine and reserpine on the toxic effects of 1-methyl-4-phenylpyridinium or 6-hydroxydopamine on nigro-striatal dopaminergic neurons.
Brain research 2003;989(2):187-95.
2003: El Yacoubi Malika; Bouali Saoussen; Popa Daniela; Naudon Laurent; Leroux-Nicollet Isabelle; Hamon Michel; Costentin Jean; Adrien Joëlle; Vaugeois Jean-Marie
Behavioral, neurochemical, and electrophysiological characterization of a genetic mouse model of depression.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(10):6227-32.
2003: Costentin Jean
[Physiological and neurobiological aspects of eating]
Bulletin de l'Académie nationale de médecine 2003;187(7):1367-76; discussion 1376-7.
2002: Le Cudennec C; Naudin B; Do Rego J-C; Costentin J
Nociceptin/orphanin FQ and related peptides reduce the increase in plasma corticosterone elicited in mice by an intracerebroventricular injection.
Life sciences 2002;72(2):163-71.
2002: Vilpoux Catherine; Carpentier Céline; Leroux-Nicollet Isabelle; Naudon Laurent; Costentin Jean
Differential effects of chronic antidepressant treatments on micro- and delta-opioid receptors in rat brain.
European journal of pharmacology 2002;443(1-3):85-93.
2002: Le Cudennec C; Suaudeau C; Costentin J
Evidence for a localization of [(3)H]nociceptin binding sites on medullar primary afferent fibers.
Journal of neuroscience research 2002;68(4):496-500.
2002: Naudon Laurent; El Yacoubi Malika; Vaugeois Jean-Marie; Leroux-Nicollet Isabelle; Costentin Jean
A chronic treatment with fluoxetine decreases 5-HT(1A) receptors labeling in mice selected as a genetic model of helplessness.
Brain research 2002;936(1-2):68-75.
2002: Do-Rego Jean-Claude; Suaudeau Charles; Chapouthier Georges; Costentin Jean
Mouse lines differing in sensitivity to beta-CCM differ in tasks used for testing antidepressants.
Pharmacology, biochemistry, and behavior 2002;72(1-2):411-6.
2002: Vilpoux Catherine; Naudon Laurent; Costentin Jean; Leroux-Nicollet Isabelle
Chronic paroxetine increases [3H]nociceptin binding in rat dorsal raphe nucleus.
Neuroreport 2002;13(1):111-4.
2002: Costentin Jean
[Recent neurobiological data on cannabis]
Bulletin de l'Académie nationale de médecine 2002;186(2):319-28; discussion 329.
2001: Leprince J; Oulyadi H; Vaudry D; Masmoudi O; Gandolfo P; Patte C; Costentin J; Fauchère J L; Davoust D; Vaudry H; Tonon M C
Synthesis, conformational analysis and biological activity of cyclic analogs of the octadecaneuropeptide ODN. Design of a potent endozepine antagonist.
European journal of biochemistry / FEBS 2001;268(23):6045-57.
2001: El Yacoubi M; Ledent C; Parmentier M; Ongini E; Costentin J; Vaugeois J M
In vivo labelling of the adenosine A2A receptor in mouse brain using the selective antagonist [3H]SCH 58261.
The European journal of neuroscience 2001;14(9):1567-70.
2001: El Yacoubi M; Ledent C; Parmentier M; Bertorelli R; Ongini E; Costentin J; Vaugeois J M
Adenosine A2A receptor antagonists are potential antidepressants: evidence based on pharmacology and A2A receptor knockout mice.
British journal of pharmacology 2001;134(1):68-77.
2001: Syringas M; Janin F; Giros B; Costentin J; Bonnet J J
Involvement of the NH2 terminal domain of catecholamine transporters in the Na(2+) and Cl(-)-dependence of a [3H]-dopamine uptake.
British journal of pharmacology 2001;133(3):387-94.
2001: El Yacoubi M; Ledent C; Parmentier M; Costentin J; Vaugeois J M
Adenosine A2A receptor knockout mice are partially protected against drug-induced catalepsy.
Neuroreport 2001;12(5):983-6.
2001: Asselin M L; Dubuc I; Coquerel A; Costentin J
Localization of neurotensin NTS2 receptors in rat brain, using.
Neuroreport 2001;12(5):1087-91.
2001: Tidjane Corera A; Do-Régo J C; Costentin J; Bonnet J J
Differential sensitivity to NaCl for inhibitors and substrates that recognize mutually exclusive binding sites on the neuronal transporter of dopamine in rat striatal membranes.
Neuroscience research 2001;39(3):319-25.
2001: de Mateos-Verchere J G; Leprince J; Tonon M C; Vaudry H; Costentin J
The octadecaneuropeptide [diazepam-binding inhibitor (33-50)] exerts potent anorexigenic effects in rodents.
European journal of pharmacology 2001;414(2-3):225-31.
2001: El Yacoubi M; Ledent C; Parmentier M; Daoust M; Costentin J; Vaugeois J
Absence of the adenosine A(2A) receptor or its chronic blockade decrease ethanol withdrawal-induced seizures in mice.
Neuropharmacology 2001;40(3):424-32.
2001: Liu J; Dong C; Cazin L; Clabaut M; Dubuc I; Costentin J; Coquerel A
Developmental changes of (3)H-labelled mu-opioid receptors in brainstems of intra-uterine growth-restricted rats.
Brain research. Developmental brain research 2001;126(2):211-5.
2001: Naudon L; Leroux-Nicollet I; Boulay D; Costentin J
Decreased densities of dopamine and serotonin transporters and of vesicular monoamine transporter 2 in severely kainic acid lesioned subregions of the striatum.
Journal of neural transmission (Vienna, Austria : 1996) 2001;108(4):431-44.
2000: Suaudeau C; Rinaldi D; Lepicard E; Venault P; Crusio W E; Costentin J; Chapouthier G
Divergent levels of anxiety in mice selected for differences in sensitivity to a convulsant agent.
Physiology & behavior 2000;71(5):517-23.
2000: Syringas M; Janin F; Mezghanni S; Giros B; Costentin J; Bonnet J J
Structural domains of chimeric dopamine-noradrenaline human transporters involved in the Na(+)- and Cl(-)-dependence of dopamine transport.
Molecular pharmacology 2000;58(6):1404-11.
2000: Florin S; Meunier J; Costentin J
Autoradiographic localization of [3H]nociceptin binding sites in the rat brain.
Brain research 2000;880(1-2):11-6.
2000: Corera A T; Costentin J; Bonnet J J
Binding of uptake blockers to the neuronal dopamine transporter: further investigation about cationic and anionic requirements.
Naunyn-Schmiedeberg's archives of pharmacology 2000;362(3):213-21.
2000: El Yacoubi M; Ledent C; Parmentier M; Costentin J; Vaugeois J
SCH 58261 and ZM 241385 differentially prevent the motor effects of CGS 21680 in mice: evidence for a functional 'atypical' adenosine A(2A) receptor.
European journal of pharmacology 2000;401(1):63-77.
2000: Suaudeau C; Costentin J
Long lasting increase in nociceptive threshold induced in mice by forced swimming: involvement of an endorphinergic mechanism.
Stress (Amsterdam, Netherlands) 2000;3(3):221-7.
2000: El Yacoubi M; Ledent C; Ménard J F; Parmentier M; Costentin J; Vaugeois J M
The stimulant effects of caffeine on locomotor behaviour in mice are mediated through its blockade of adenosine A(2A) receptors.
British journal of pharmacology 2000;129(7):1465-73.
2000: Vilpoux C; Leroux-Nicollet I; Naudon L; Raisman-Vozari R; Costentin J
Reserpine or chronic paroxetine treatments do not modify the vesicular monoamine transporter 2 expression in serotonin-containing regions of the rat brain.
Neuropharmacology 2000;39(6):1075-82.
2000: Costentin J
[Pain and its main transmitters]
Annales pharmaceutiques françaises 2000;58(2):77-83.
2000: Nail-Boucherie K; Dourmap N; Jaffard R; Costentin J
Contextual fear conditioning is associated with an increase of acetylcholine release in the hippocampus of rat.
Brain research. Cognitive brain research 2000;9(2):193-7.
2000: El Yacoubi M; Ledent C; Parmentier M; Costentin J; Vaugeois J M
The anxiogenic-like effect of caffeine in two experimental procedures measuring anxiety in the mouse is not shared by selective A(2A) adenosine receptor antagonists.
Psychopharmacology 2000;148(2):153-63.
1999: Garcia de Mateos-Verchere J; Leprince J; Tonon M C; Vaudry H; Costentin J
Reduction of pentylenetetrazol-induced convulsions by the octadecaneuropeptide ODN.
Peptides 1999;20(12):1431-6.
1999: Dubuc I; Remande S; Costentin J
The partial agonist properties of levocabastine in neurotensin-induced analgesia.
European journal of pharmacology 1999;381(1):9-12.
1999: Régo J C; Syringas M; Leblond B; Costentin J; Bonnet J J
Recovery of dopamine neuronal transporter but lack of change of its mRNA in substantia nigra after inactivation by a new irreversible inhibitor characterized in vitro and ex vivo in the rat.
British journal of pharmacology 1999;128(1):51-60.
1999: Vaugeois J M; Corera A T; Deslandes A; Costentin J
Although chemically related to amineptine, the antidepressant tianeptine is not a dopamine uptake inhibitor.
Pharmacology, biochemistry, and behavior 1999;63(2):285-90.
1999: Cleren C; Vilpoux C; Dourmap N; Bonnet J J; Costentin J
Acute interactions between L-DOPA and the neurotoxic effects of 1-methyl-4-phenylpyridinium or 6-hydroxydopamine in mice.
Brain research 1999;830(2):314-9.
1999: Do-Régo J C; Hue H; Costentin J; Bonnet J J
Evidence for the sequential formation of two complexes between an uptake inhibitor, GBR 12783 [1-[2-(diphenylmethoxy)ethyl]-4-(3-phenyl-2-propenyl)piperazine], and the neuronal transporter of dopamine.
Journal of neurochemistry 1999;72(1):396-404.
1999: Dubuc I; Sarret P; Labbé-Jullié C; Botto J M; Honoré E; Bourdel E; Martinez J; Costentin J; Vincent J P; Kitabgi P; Mazella J
Identification of the receptor subtype involved in the analgesic effect of neurotensin.
The Journal of neuroscience : the official journal of the Society for Neuroscience 1999;19(1):503-10.
1999: Florin S; Leblond F; Suaudeau C; Meunier J C; Costentin J
Comparison of behavioural effects of NocII or NocIII, two related pronociceptin-derived peptides.
Life sciences 1999;65(25):2727-33.
1999: Condamine E; Leprince J; Suaudeau C; Mayer C; Davoust D; Costentin J; Vaudry H
The proenkephalin A-processing product peptide E, which encompasses two enkephalin sequences, has a much lower opioid activity than beta-endorphin.
Peptides 1999;20(7):865-71.
1998: Garcia de Mateos-Verchere J; Vaugeois J M; Naudin B; Costentin J
Behavioural and neurochemical evidence that the antimicrobial agent oxolinic acid is a dopamine uptake inhibitor.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 1998;8(4):255-9.
1998: Nail-Boucherie K; Dourmap N; Jaffard R; Costentin J
The specific dopamine uptake inhibitor GBR 12783 improves learning of inhibitory avoidance and increases hippocampal acetylcholine release.
Brain research. Cognitive brain research 1998;7(2):203-5.
1998: Garcia de Mateos-Verchere J; Leprince J; Tonon M C; Vaudry H; Costentin J
The octadecaneuropeptide ODN inhibits apomorphine-induced yawning in rats.
European journal of pharmacology 1998;357(2-3):121-6.
1998: Le Pen G; Duterte-Boucher D; Daoust M; Costentin J
Pre-exposure to alcohol does not sensitize to the rewarding effects of cocaine.
Neuroreport 1998;9(12):2887-91.
1998: Le Pen G; Duterte-Boucher D; Costentin J
Sensitization to the rewarding effects of the specific dopamine uptake inhibitor GBR12783.
The Journal of pharmacology and experimental therapeutics 1998;286(2):688-96.
1998: Leroux-Nicollet I; Costentin J
Transient expression of the vesicular monoamine transporter during development in the rat thalamus and cortex.
Neuroscience letters 1998;248(3):167-70.
1998: Vaugeois J M; Costentin J
[Creation of a line of "depressed" mice from a selection of breeders exhibiting a behavioral helplessness]
Comptes rendus des séances de la Société de biologie et de ses filiales 1998;192(6):1149-61.
1998: Costentin J; Florin S; Suaudeau C; Meunier J C
[Cloning of prepronociceptin has led to the discovery of other biologically active peptides]
Comptes rendus des séances de la Société de biologie et de ses filiales 1998;192(6):1099-109.
1998: Costentin J
[From gene to behavior, a new method for elaboration of new psychotropic agents]
Annales pharmaceutiques françaises 1998;56(2):60-7.
1998: Suaudeau C; Florin S; Meunier J C; Costentin J
Nociceptin-induced apparent hyperalgesia in mice as a result of the prevention of opioid autoanalgesic mechanisms triggered by the stress of an intracerebroventricular injection.
Fundamental & clinical pharmacology 1998;12(4):420-5.
1998: De Mateos-Verchere J G; Leprince J; Tonon M C; Vaudry H; Costentin J
The octadecaneuropeptide ODN induces anxiety in rodents: possible involvement of a shorter biologically active fragment.
Peptides 1998;19(5):841-8.
1997: Vaugeois J M; Passera G; Zuccaro F; Costentin J
Individual differences in response to imipramine in the mouse tail suspension test.
Psychopharmacology 1997;134(4):387-91.
1997: Ledent C; Vaugeois J M; Schiffmann S N; Pedrazzini T; El Yacoubi M; Vanderhaeghen J J; Costentin J; Heath J K; Vassart G; Parmentier M
Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor.
Nature 1997;388(6643):674-8.
1997: Florin S; Leroux-Nicollet I; Meunier J C; Costentin J
Autoradiographic localization of [3H]nociceptin binding sites from telencephalic to mesencephalic regions of the mouse brain.
Neuroscience letters 1997;230(1):33-6.
1997: Drouet I; Suaudeau C; Dourmap N; Costentin J
Mechanism of the hypothermic effect of MPP+ administered centrally in mice.
Neuropharmacology 1997;36(7):993-7.
1997: Costentin J
[From gene to behavior, a new way for elaborating new psychotropic agents]
Bulletin de l'Académie nationale de médecine 1997;181(6):1057-69; discussion 1069-71.
1997: Dourmap N; Clero E; Costentin J
Involvement of cholinergic neurons in the release of dopamine elicited by stimulation of mu-opioid receptors in striatum.
Brain research 1997;749(2):295-300.
1997: Florin S; Suaudeau C; Meunier J C; Costentin J
Orphan neuropeptide NocII, a putative pronociceptin maturation product, stimulates locomotion in mice.
Neuroreport 1997;8(3):705-7.
1996: Florin S; Suaudeau C; Meunier J C; Costentin J
Nociceptin stimulates locomotion and exploratory behaviour in mice.
European journal of pharmacology 1996;317(1):9-13.
1996: Vaugeois J M; Odièvre C; Loisel L; Costentin J
A genetic mouse model of helplessness sensitive to imipramine.
European journal of pharmacology 1996;316(2-3):R1-2.
1996: Le Pen G; Duterte-Boucher D; Costentin J
Place conditioning with cocaine and the dopamine uptake inhibitor GBR12783.
Neuroreport 1996;7(18):2839-42.
1996: Van Kemmel F M; Dubuc I; Bourdel E; Fehrentz J A; Martinez J; Costentin J
A C-terminal cyclic 8-13 neurotensin fragment analog appears less exposed to neprilysin when it crosses the blood-brain barrier than the cerebrospinal fluid-brain barrier in mice.
Neuroscience letters 1996;217(1):58-60.
1996: Boulay D; Duterte-Boucher D; Leroux-Nicollet I; Naudon L; Costentin J
Locomotor sensitization and decrease in [3H]mazindol binding to the dopamine transporter in the nucleus accumbens are delayed after chronic treatments by GBR12783 or cocaine.
The Journal of pharmacology and experimental therapeutics 1996;278(1):330-7.
1996: Vaugeois J M; Pouhé D; Zuccaro F; Costentin J
Indirect dopamine agonists effects on despair test: dissociation from hyperactivity.
Pharmacology, biochemistry, and behavior 1996;54(1):235-9.
1996: Naudon L; Raisman-Vozari R; Edwards R H; Leroux-Nicollet I; Peter D; Liu Y; Costentin J
Reserpine affects differentially the density of the vesicular monoamine transporter and dihydrotetrabenazine binding sites.
The European journal of neuroscience 1996;8(4):842-6.
1996: Boulay D; Duterte-Boucher D; Nouel D; Costentin J
Locomotor sensitization to [D-Trp(11)]neurotensin after repeated injections of the dopamine uptake inhibitor GBR12783 in rats.
Neuroscience letters 1996;208(1):5-8.
1996: Thibaut F; Bonnet J J; Vaugeois J M; Costentin J
Pharmacological modifications of dopamine transmission do not influence the striatal in vivo binding of [3H]mazindol or [3H]cocaine in mice.
Neuroscience letters 1996;205(3):145-8.
1996: Thibaut F; Vaugeois J M; Bonnet J J; Costentin J
In vivo striatal binding of the D1 antagonist SCH 23390 is not modified by changes in dopaminergic transmission.
Neuropharmacology 1996;35(3):267-72.
1996: Simon P; Hémet C; Costentin J
Analysis of stimulant locomotor effects of modafinil in various strains of mice and rats.
Fundamental & clinical pharmacology 1996;10(5):431-5.
1995: Simon P; Hémet C; Ramassamy C; Costentin J
Non-amphetaminic mechanism of stimulant locomotor effect of modafinil in mice.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 1995;5(4):509-14.
1995: Naudon L; Leroux-Nicollet I; Raisman-Vozari R; Botton D; Costentin J
Time-course of modifications elicited by reserpine on the density and mRNA synthesis of the vesicular monoamine transporter, and on the density of the membrane dopamine uptake complex.
Synapse (New York, N.Y.) 1995;21(1):29-36.
1995: Ramassamy C; Girbe F; Christen Y; Costentin J
Peroxidation of synaptosomes alters the dopamine uptake complex but spares the exocytotic release of dopamine.
Neurodegeneration : a journal for neurodegenerative disorders, neuroprotection, and neuroregeneration 1995;4(2):155-60.
1995: Suaudeau C; Dourmap N; Costentin J
Rapid and long lasting reduction of the hypothermic effect of a D2 dopamine agonist after an intracerebroventricular injection of 6-hydroxydopamine.
Neuropharmacology 1995;34(1):101-5.
1995: Suaudeau C; Costentin J
Analgesic effect of the direct D2 dopamine receptor agonist RU 24926 and cross tolerance with morphine.
Fundamental & clinical pharmacology 1995;9(2):147-52.
1994: Ramassamy C; Girbe F; Pincemail J; Christen Y; Costentin J
Modifications of the synaptosomal dopamine uptake and release by two systems generating free radicals: ascorbic acid/Fe2+ and L-arginine/NADPH.
Annals of the New York Academy of Sciences 1994;738():141-52.
1994: Dubuc I; Costentin J; Terranova J P; Barnouin M C; Soubrié P; Le Fur G; Rostène W; Kitabgi P
The nonpeptide neurotensin antagonist, SR 48692, used as a tool to reveal putative neurotensin receptor subtypes.
British journal of pharmacology 1994;112(2):352-4.
1994: Khallouk-Bousselmame R; Costentin J
Locomotor and analgesic effects of morphine and acetorphan in rats chronically treated with morphine or thiorphan.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 1994;4(2):137-43.
1994: Girbe F; Ramassamy C; Piton C; Costentin J
Ascorbic acid increases synaptosomal potassium-induced dopamine release.
Neuroreport 1994;5(9):1027-9.
1994: Simon P; Panissaud C; Costentin J
The stimulant effect of modafinil on wakefulness is not associated with an increase in anxiety in mice. A comparison with dexamphetamine.
Psychopharmacology 1994;114(4):597-600.
1994: Naudon L; Leroux-Nicollet I; Costentin J
Short-term treatments with haloperidol or bromocriptine do not alter the density of the monoamine vesicular transporter in the substantia nigra.
Neuroscience letters 1994;173(1-2):1-4.
1994: Dourmap N; Costentin J
Involvement of glutamate receptors in the striatal enkephalin-induced dopamine release.
European journal of pharmacology 1994;253(3):R9-11.
1994: Simon P; Dupuis R; Costentin J
Thigmotaxis as an index of anxiety in mice. Influence of dopaminergic transmissions.
Behavioural brain research 1994;61(1):59-64.
1994: Labbé-Jullié C; Dubuc I; Brouard A; Doulut S; Bourdel E; Pelaprat D; Mazella J; Martinez J; Rostène W; Costentin J
In vivo and in vitro structure-activity studies with peptide and pseudopeptide neurotensin analogs suggest the existence of distinct central neurotensin receptor subtypes.
The Journal of pharmacology and experimental therapeutics 1994;268(1):328-36.
1994: Bonnet J J; Benmansour S; Amejdki-Chab N; Costentin J
Effect of CH3HgCl and several transition metals on the dopamine neuronal carrier; peculiar behaviour of Zn2+.
European journal of pharmacology 1994;266(1):87-97.
1994: Leroux-Nicollet I; Costentin J
Comparison of the subregional distributions of the monoamine vesicular transporter and dopamine uptake complex in the rat striatum and changes during aging.
Journal of neural transmission. General section 1994;97(2):93-106.
1994: Boulay D; Leroux-Nicollet I; Duterte-Boucher D; Naudon L; Costentin J
Invariance of the density of dopamine uptake sites and dopamine metabolism in the rat brain after a chronic treatment with the dopamine uptake inhibitor GBR 12783.
Journal of neural transmission. General section 1994;98(3):209-15.
1993: Simon P; Bertrand J; Costentin J
5-HT1A receptor blockade increases penile erections induced by indirect serotonin agonists.
Neuroreport 1993;5(3):229-30.
1993: Simon P; Panissaud C; Costentin J
Anxiogenic-like effects induced by stimulation of dopamine receptors.
Pharmacology, biochemistry, and behavior 1993;45(3):685-90.
1993: Vaugeois J M; Bonnet J J; Duterte-Boucher D; Costentin J
In vivo occupancy of the striatal dopamine uptake complex by various inhibitors does not predict their effects on locomotion.
European journal of pharmacology 1993;230(2):195-201.
1993: Ramassamy C; Girbe F; Christen Y; Costentin J
Ginkgo biloba extract EGb 761 or trolox C prevent the ascorbic acid/Fe2+ induced decrease in synaptosomal membrane fluidity.
Free radical research communications 1993;19(5):341-50.
1992: Ramassamy C; Naudin B; Christen Y; Clostre F; Costentin J
Prevention by Ginkgo biloba extract (EGb 761) and trolox C of the decrease in synaptosomal dopamine or serotonin uptake following incubation.
Biochemical pharmacology 1992;44(12):2395-401.
1992: Suaudeau C; Bousselmame R; Costentin J
A different balance in the sensitivity of D1 and D2 dopamine receptors accounts for differences in apomorphine-induced hypothermic effects in Swiss and C3H mice.
Neuropharmacology 1992;31(11):1115-9.
1992: Amejdki-Chab N; Benmansour S; Costentin J; Bonnet J J
Effects of several cations on the neuronal uptake of dopamine and the specific binding of [3H]GBR 12783: attempts to characterize the Na+ dependence of the neuronal transport of dopamine.
Journal of neurochemistry 1992;59(5):1795-804.
1992: Ramassamy C; Christen Y; Clostre F; Costentin J
The Ginkgo biloba extract, EGb761, increases synaptosomal uptake of 5-hydroxytryptamine: in-vitro and ex-vivo studies.
The Journal of pharmacy and pharmacology 1992;44(11):943-5.
1992: Nouel D; Costentin J; Lugrin D; Kitabgi P; Ple N; Davoust D
Investigations about a direct neurotensin-dopamine interaction by nuclear magnetic resonance study, synaptosomal uptake of dopamine, and binding of neurotensin to its receptors.
Journal of neurochemistry 1992;59(5):1933-6.
1992: Naudon L; Leroux-Nicollet I; Costentin J
Consequences of an intrastriatal injection of kainic acid on the dopaminergic neuronal and vesicular uptake systems.
Brain research 1992;593(1):32-8.
1992: Kitabgi P; Dubuc I; Nouel D; Costentin J; Cuber J C; Fulcrand H; Doulut S; Rodriguez M; Martinez J
Effects of thiorphan, bestatin and a novel metallopeptidase inhibitor JMV 390-1 on the recovery of neurotensin and neuromedin N released from mouse hypothalamus.
Neuroscience letters 1992;142(2):200-4.
1992: Dubuc I; Costentin J; Doulut S; Rodriguez M; Martinez J; Kitabgi P
JMV 449: a pseudopeptide analogue of neurotensin-(8-13) with highly potent and long-lasting hypothermic and analgesic effects in the mouse.
European journal of pharmacology 1992;219(2):327-9.
1992: Amejdki-Chab N; Costentin J; Bonnet J J
Kinetic analysis of the chloride dependence of the neuronal uptake of dopamine and effect of anions on the ability of substrates to compete with the binding of the dopamine uptake inhibitor GBR 12783.
Journal of neurochemistry 1992;58(3):793-800.
1992: Dourmap N; Michael-Titus A; Costentin J
Differential effect of intrastriatal kainic acid on the modulation of dopamine release by mu- and delta-opioid peptides: a microdialysis study.
Journal of neurochemistry 1992;58(2):709-13.
1992: Naudon L; Dourmap N; Leroux-Nicollet I; Costentin J
Kainic acid lesion of the striatum increases dopamine release but reduces 3-methoxytyramine level.
Brain research 1992;572(1-2):247-9.
1992: Vaugeois J M; Bonnet J J; Costentin J
In vivo labelling of the neuronal dopamine uptake complex in the mouse striatum by [3H]GBR 12783.
European journal of pharmacology 1992;210(1):77-84.
1992: Duterte-Boucher D; Duhamel F; Costentin J
Dopaminergic transmission and (+)amphetamine-induced lethality in aggregated mice.
Fundamental & clinical pharmacology 1992;6(1):21-7.
1992: Kitabgi P; De Nadai F; Labbe-Jullie C; Dubuc I; Nouel D; Costentin J; Masuo Y; Rostene W; Woulfe J; Lafortune L
Functional and pharmacological aspects of central neuropeptidergic transmission mediated by neurotensin and neuromedin n.
Clinical neuropharmacology 1992;15 Suppl 1 Pt A():313A-314A.
1991: Bousselmame R; Michael-Titus A; Costentin J
Desensitization of mu-opioid receptors does not modify the analgesia induced by an enkephalinase inhibitor.
European journal of pharmacology 1991;203(2):295-7.
1991: Naudin B; Saligaut C; Costentin J
Influence of oxygen availability on the neurotoxic effect of 6-hydroxydopamine on nigro-striatal dopaminergic neurons.
Neuroscience letters 1991;130(1):22-6.
1991: Bousselmame R; Eustache M; Michael-Titus A; Costentin J
Chronic inhibition of enkephalinase induces changes in the antinociceptive and locomotor effects of the enkephalinase inhibitor acetorphan in rats.
Neuropharmacology 1991;30(8):865-70.
1991: Costentin J
[Brain dopamine receptors. Interactions between D1 and D2 receptors, and dopamine mediated behaviour]
Thérapie 1991;46(4):269-82.
1991: Costentin J
[The pharmacologist facing the neuroleptics]
L'Encéphale 1991;17 Spec No 2():153-7.
1990: Ramassamy C; Clostre F; Christen Y; Costentin J
Prevention by a Ginkgo biloba extract (GBE 761) of the dopaminergic neurotoxicity of MPTP.
The Journal of pharmacy and pharmacology 1990;42(11):785-9.
1990: Michael-Titus A; Bousselmame R; Costentin J
Stimulation of dopamine D2 receptors induces an analgesia involving an opioidergic but non enkephalinergic link.
European journal of pharmacology 1990;187(2):201-7.
1990: Leroux-Nicollet I; Darchen F; Scherman D; Costentin J
Postnatal development of the monoamine vesicular transporter in mesencephalic and telencephalic regions of the rat brain: a quantitative autoradiographic study with [3H]dihydrotetrabenazine.
Neuroscience letters 1990;117(1-2):1-7.
1990: Dourmap N; Michael-Titus A; Costentin J
Local enkephalins tonically modulate dopamine release in the striatum: a microdialysis study.
Brain research 1990;524(1):153-5.
1990: Bonnet J J; Benmansour S; Costentin J; Parker E M; Cubeddu L X
Thermodynamic analyses of the binding of substrates and uptake inhibitors on the neuronal carrier of dopamine labeled with [3H]GBR 12783 or [3H]mazindol.
The Journal of pharmacology and experimental therapeutics 1990;253(3):1206-14.
1990: Nouel D; Dubuc I; Kitabgi P; Costentin J
Centrally administered [D-Trp11]neurotensin, as well as neurotensin protected from inactivation by thiorphan, modifies locomotion in rats in a biphasic manner.
Peptides 1990;11(3):551-5.
1990: Vaugeois J M; Bonnet J J; Costentin J
Relationship between the effects of dexamphetamine on locomotion and on striatal [3H]GBR 12783 binding in vivo.
European journal of pharmacology 1990;178(2):221-7.
1990: Kitabgi P; De Nadai F; Cuber J C; Dubuc I; Nouel D; Costentin J
Calcium-dependent release of neuromedin N and neurotensin from mouse hypothalamus.
Neuropeptides 1990;15(2):111-4.
1990: Michael-Titus A; Dourmap N; Costentin J; Schwartz J C
Role of delta opioid receptors in the effects of inhibitors of enkephalin-degrading peptidases on the horizontal and vertical components of locomotion in mice.
Neuropeptides 1990;15(2):89-100.
1990: Costentin J; Duterte-Boucher D; Panissaud C; Michael-Titus A
Dopamine D1 and D2 receptors mediate opposite effects of apomorphine on the body temperature of reserpinized mice.
Neuropharmacology 1990;29(1):31-5.
1990: Naudin B; Canu S; Costentin J
Effects of various direct or indirect dopamine agonists on the latency of the acoustic startle response in rats.
Journal of neural transmission. General section 1990;82(1):43-53.
1990: Duterte-Boucher D; Kamenka J M; Costentin J
Comparison of the effects of three indirect dopamine agonists, GK 13, GBR 12783 and dexamphetamine on behavioural tests involving central catecholaminergic transmissions.
Psychopharmacology 1990;101(3):344-53.
1989: Michael-Titus A; Dourmap N; Costentin J
MU and delta opioid receptors control differently the horizontal and vertical components of locomotor activity in mice.
Neuropeptides 1989;13(4):235-42.
1989: Duterte-Boucher D; Panissaud C; Michael-Titus A; Costentin J
Stimulation of central D1 dopamine receptors reverses reserpine-induced hypothermia in mice.
Neuropharmacology 1989;28(4):419-21.
1989: Michael-Titus A; Dourmap N; Caline H; Costentin J; Schwartz J C
Role of endogenous enkephalins in locomotion and nociception studied with peptidase inhibitors in two inbred strains of mice (C57BL/6J and DBA/2J).
Neuropharmacology 1989;28(2):117-22.
1989: Thibaut F; Bonnet J J; Costentin J
Time course of postmortem modifications in synaptosomal [3H]dopamine uptake and [3H]GBR 12783 binding to the dopamine uptake complex in the rat striatum.
Neuroscience letters 1989;96(3):335-9.
1989: Duterte-Boucher D; Naudin B; Costentin J
Characteristics of the dopamine receptors involved in the anorectic effects of apomorphine in mice.
Fundamental & clinical pharmacology 1989;3(4):337-46.
1989: Duterte-Boucher D; Costentin J
Appearance of a stereotyped apomorphine-induced climbing in unresponsive DBA2 mice after subchronic manipulations of brain dopamine transmission.
Psychopharmacology 1989;98(1):56-60.
1988: Leroux-Nicollet I; Costentin J
In vivo and in vitro autoradiographic labelling of central dopaminergic systems with [3H]GBR12783 in rodents.
Neuroscience letters 1988;95(1-3):7-12.
1988: Duterte-Boucher D; Leclère J F; Panissaud C; Costentin J
Acute effects of direct dopamine agonists in the mouse behavioral despair test.
European journal of pharmacology 1988;154(2):185-90.
1988: Dubuc I; Nouel D; Coquerel A; Menard J F; Kitabgi P; Costentin J
Hypothermic effect of neuromedin N in mice and its potentiation by peptidase inhibitors.
European journal of pharmacology 1988;151(1):117-21.
1988: Bonnet J J; Benmansour S; Vaugeois J M; Costentin J
Ionic requirements for the specific binding of [3H]GBR 12783 to a site associated with the dopamine uptake carrier.
Journal of neurochemistry 1988;50(3):759-65.
1988: Leroux-Nicollet I; Panissaud C; Costentin J
Involvement of norepinephrine neurons in the hypothermia induced by intracerebroventricular administration of 6-hydroxydopamine in mice, evidenced by antidepressants.
Journal of neural transmission 1988;74(1):17-27.
1987: Michael-Titus A; Preterre P; Giros B; Costentin J
Role of endogenous enkephalins in locomotion evidenced by acetorphan, an "enkephalinase" inhibitor.
The Journal of pharmacology and experimental therapeutics 1987;243(3):1062-6.
1987: Michael-Titus A; Costentin J
Analgesic effects of metapramine and evidence against the involvement of endogenous enkephalins in the analgesia induced by tricyclic antidepressants.
Pain 1987;31(3):391-400.
1987: Chagraoui A; Bonnet J J; Protais P; Costentin J
In vivo binding of [3H]GBR 12783, a selective dopamine uptake inhibitor, in mouse striatum.
Neuroscience letters 1987;78(2):175-9.
1987: Benmansour S; Bonnet J J; Protais P; Costentin J
Sodium independence of the binding of [3H]GBR 12783 and other dopamine uptake inhibitors to the dopamine uptake complex.
Neuroscience letters 1987;77(1):97-102.
1987: Bonnet J J; Chagraoui A; Protais P; Costentin J
Interactions of amineptine with the neuronal dopamine uptake system: neurochemical in vitro and in vivo studies.
Journal of neural transmission 1987;69(3-4):211-20.
1986: Coquerel A; Dubuc I; Menard J F; Kitabgi P; Costentin J
Naloxone-insensitive potentiation of neurotensin hypothermic effect by the enkephalinase inhibitor thiorphan.
Brain research 1986;398(2):386-9.
1986: Bonnet J J; Protais P; Chagraoui A; Costentin J
High-affinity [3H]GBR 12783 binding to a specific site associated with the neuronal dopamine uptake complex in the central nervous system.
European journal of pharmacology 1986;126(3):211-22.
1985: Vasse M; Protais P; Costentin J; Schwartz J C
Unexpected potentiation by discriminant benzamide derivatives of stereotyped behaviours elicited by dopamine agonists in mice.
Naunyn-Schmiedeberg's archives of pharmacology 1985;329(2):108-16.
1984: Protais P; Bonnet J J; Costentin J; Schwartz J C
Rat climbing behavior elicited by stimulation of cerebral dopamine receptors.
Naunyn-Schmiedeberg's archives of pharmacology 1984;325(2):93-101.
1983: Protais P; Bonnet J J; Costentin J
Pharmacological characterization of the receptors involved in the apomorphine-induced polyphasic modifications of locomotor activity in mice.
Psychopharmacology 1983;81(2):126-34.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Jean Costentin

Research Profile (preview)

Living Beings

Chemicals & Drugs

Activities & Behaviors

Concepts & Ideas

Anatomy

Procedures

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Jean Costentin (preview)

All Publications